DYN

Dyne Therapeutics (DYN)

Dyne Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DYN

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/23	05 : 30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/22	20 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/22	09 : 39	GlobeNewswire Inc.	Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	07 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	05 : 24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/21	05 : 01	GlobeNewswire Inc.	Dyne Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/20	20 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/20	19 : 30	GlobeNewswire Inc.	Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/19	21 : 00	GlobeNewswire Inc.	Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/18	10 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/17	05 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/05/03	05 : 10	GlobeNewswire Inc.	Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/28	05 : 05	GlobeNewswire Inc.	Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/27	21 : 30	GlobeNewswire Inc.	Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/25	20 : 30	GlobeNewswire Inc.	Dyne Therapeutics Announces CEO Transition	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/13	20 : 30	GlobeNewswire Inc.	Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/12	06 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/09	06 : 53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/08	10 : 16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/05	22 : 22	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:DYN	Dyne Therapeutics Inc
2024/03/05	21 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DYN	Dyne Therapeutics Inc